We are live on ! Find out more
TAM

Tocqueville Asset Management Portfolio holdings

AUM $7.56B
1-Year Est. Return 44.87%
This Fund
S&P 500
This Quarter Est. Return
-13.28%
1 Year Est. Return
+44.87%
3 Year Est. Return
+121.98%
5 Year Est. Return
+153.06%
10 Year Est. Return
+501.33%
AUM
$5.47B
AUM Growth
-$1.15B
Cap. Flow
-$119M
Cap. Flow %
-2.18%
Top 10 Hldgs %
22.93%
Holding
735
New
29
Increased
168
Reduced
274
Closed
74

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$33.6M
2
ELAN icon
Elanco Animal Health
ELAN
+$17M
3
DCI icon
Donaldson
DCI
+$15.1M
4
DD icon
DuPont de Nemours
DD
+$13.2M
5
TIP icon
iShares TIPS Bond ETF
TIP
+$9.87M

Sector Composition

Rank Sector Weight
1 Technology 16.34%
2 Consumer Discretionary 13.6%
3 Healthcare 11.51%
4 Industrials 11.51%
5 Miscellaneous 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNMR
601
DELISTED
Danimer Scientific, Inc.
DNMR
$133K ﹤0.01%
728
MDNA
602
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$132K ﹤0.01%
113,000
+25,000
+28% +$26.7K
MGTX icon
603
MeiraGTx Holdings
MGTX
$1.36B
$129K ﹤0.01%
17,100
-1,500
-8% -$14.6K
ARC
604
DELISTED
ARC Document Solutions, Inc.
ARC
$102K ﹤0.01%
38,662
ARAY icon
605
Accuray
ARAY
$31.3M
$88K ﹤0.01%
45,000
VRT icon
606
Vertiv
VRT
$103B
$82K ﹤0.01%
+10,000
New +$113K
SEEL
607
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$81K ﹤0.01%
31
SGMO
608
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$73K ﹤0.01%
17,580
-2,000
-10% -$8.65K
SPOK icon
609
Spok Holdings
SPOK
$217M
$66K ﹤0.01%
10,500
NBSE
610
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$56K ﹤0.01%
2,675
ONCS
611
DELISTED
OncoSec Medical Incorporated
ONCS
$55K ﹤0.01%
3,386
-46
-1% -$882
ZVIA icon
612
Zevia
ZVIA
$102M
$42K ﹤0.01%
15,000
ACXP icon
613
Acurx Pharmaceuticals
ACXP
$6.1M
$38K ﹤0.01%
505
ATYR
614
aTyr Pharma
ATYR
$54.5M
$29K ﹤0.01%
10,150
NMTR
615
DELISTED
9 Meters Biopharma
NMTR
$3K ﹤0.01%
510
AA icon
616
Alcoa
AA
$13.6B
-2,513
Closed -$226K
ACWX icon
617
iShares MSCI ACWI ex US ETF
ACWX
$12.5B
-5,920
Closed -$309K
AMP icon
618
Ameriprise Financial
AMP
$49.1B
-905
Closed -$272K
AMT icon
619
American Tower
AMT
$81.2B
-1,110
Closed -$279K
AZZ icon
620
AZZ Inc
AZZ
$4.2B
-12,080
Closed -$583K
BFAM icon
621
Bright Horizons
BFAM
$3.61B
-1,700
Closed -$226K
BLBD icon
622
Blue Bird Corp
BLBD
$1.91B
-23,544
Closed -$443K
BLK icon
623
Blackrock
BLK
$181B
-265
Closed -$203K
CAKE icon
624
Cheesecake Factory
CAKE
$5.52B
-8,500
Closed -$338K
CE icon
625
Celanese
CE
$4.9B
-1,951
Closed -$279K

Similar funds

Tocqueville Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Tocqueville Asset Management held 735 positions worth $5.47B, down 17% from $6.62B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tocqueville Asset Management's Q2 2022 filing shows 29 new, 168 increased, 274 reduced and 74 closed positions. Its largest new stake was Occidental Petroleum: 238,298 shares worth $14M. The largest sale was Home Depot, an estimated $33.6M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Tocqueville Asset Management's largest Q2 2022 buy was Occidental Petroleum: 238,298 shares worth $14M.
  • Tocqueville Asset Management added most to iShares Gold Trust in Q2 2022, an estimated $16.1M increase.
  • Tocqueville Asset Management's biggest Q2 2022 reduction was Home Depot, cutting an estimated $33.6M.
  • Tocqueville Asset Management fully exited ScottsMiracle-Gro in Q2 2022, selling an estimated $9.61M.
  • Tocqueville Asset Management's ten largest holdings make up 23% of its $5.47B portfolio in Q2 2022.
  • Tocqueville Asset Management opened 29 new positions and closed 74 in Q2 2022.
  • Tocqueville Asset Management's portfolio value fell 17% quarter-over-quarter to $5.47B.

Based on Tocqueville Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.